The value of breast palpation imaging in breast cancer screening_CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

Authors：

QU Fan , HE Xiaoliang , LAI Yuzhou ,  TIAN Chao

Department of Breast Surgery, Sichuan Cancer Hospital & Institute; Affiliated Cancer Hospital of University of Electronic Science and Technology of China, Chengdu 610042, P. R. China;

Corresponding?author：

TIAN Chao, Email: petrichor8293@163.com

Keywords：

breast cancer; palpation imaging; clinical breast examination; mammography; breast ultrasound

DOI：

10.7507/1007-9424.202209101

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Objective To describe the role of breast palpation imaging (PI) in breast cancer screening. Method We searched the latest research and previous literatures of PI in the diagnosis of breast cancers, and made an review after reading the articles. Results PI had better diagnostic efficiency than clinical breast examination (CBE) in breast cancer screening. PI combined with mammography (MG) and/or breast ultrasound (BUS) could further improve the diagnostic efficiency. Conclusion PI has important value in breast cancer screening, and is an important supplement to existing breast cancer screening methods.

Citation： QU Fan, HE Xiaoliang, LAI Yuzhou, TIAN Chao. The value of breast palpation imaging in breast cancer screening. CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY, 2023, 30(3): 353-357. doi: 10.7507/1007-9424.202209101 Copy

1.	Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
2.	孫可欣, 鄭榮壽, 顧秀瑛, 等. 2000—2014年中國腫瘤登記地區女性乳腺癌發病趨勢及年齡變化情況分析. 中華預防醫學雜志, 2018, 52(6): 567-572.
3.	沈松杰, 孫強. 制定中國女性乳腺癌篩查指南的意義. 中國研究型醫院, 2022, 9(2): 23-27.
4.	von Euler-Chelpin M, Lillholm M, Vejborg I, et al. Sensitivity of screening mammography by density and texture: a cohort study from a population-based screening program in Denmark. Breast Cancer Res, 2019, 21(1): 111. doi: 10.1186/s13058-019-1203-3.
5.	赫捷, 陳萬青, 李霓, 等. 中國女性乳腺癌篩查與早診早治指南(2021, 北京). 中華腫瘤雜志, 2021, 43(4): 357-382.
6.	張敏璐, 彭鵬, 吳春曉, 等. 2008–2012年中國腫瘤登記地區女性乳腺癌發病和死亡分析. 中華腫瘤雜志, 2019, 41(4): 315-320.
7.	劉慧杰, 劉迪. 超聲乳腺影像報告和數據系統分級在篩查社區女性乳腺癌中的應用. 當代醫學, 2022, 28(11): 152-154.
8.	孫鑫, 韓優莉, 王樂, 等. 超聲檢查用于亞洲女性乳腺癌篩查衛生經濟學研究的系統評價. 中國腫瘤, 2018, 27(7): 553-560.
9.	中國抗癌協會乳腺癌專業委員會. 中國乳腺癌篩查與早期診斷指南. 中國癌癥雜志, 2022, 32(4): 363-372.
10.	Kiely BE, Goodwin A. Is it time to abandon clinical breast examination? Med J Aust, 2021, 215(10): 458-459.
11.	Egorov V, Sarvazyan AP. Mechanical imaging of the breast. IEEE Trans Med Imaging, 2008, 27(9): 1275-1287.
12.	Ding Y, Sun C, Zhou Q, et al. Use of palpation imaging in diagnosis of breast diseases: A way to improve the detection rate. Med Sci Monit, 2020, 26: e927553. doi: 10.12659/MSM.927553.
13.	Romanoff A, Constant TH, Johnson KM, et al. Association of previous clinical breast examination with reduced delays and earlier-stage breast cancer diagnosis among women in peru. JAMA Oncol, 2017, 3(11): 1563-1567.
14.	Mittra I, Mishra GA, Dikshit RP, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ, 2021, 372: n256. doi: 10.1136/bmj.n256.
15.	Malmartel A, Tron A, Caulliez S. Accuracy of clinical breast examination's abnormalities for breast cancer screening: cross-sectional study. Eur J Obstet Gynecol Reprod Biol, 2019, 237: 1-6.
16.	NCCN. Breast cancer screening and diagnosis. (version 2022). https://www.nccn.org/patients/guidelines/content/PDF/breastcancerscreening-patient.pdf.
17.	Committee on Practice Bulletins—Gynecology. Practice bulletin number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol, 2017, 130(1): e1-e16. doi: 10.1097/AOG.0000000000002158.
18.	沈松杰, 孫強, 黃欣, 等. 中國女性乳腺癌篩查指南(2022年版). 中國研究型醫院, 2022, 9(2): 6-13.
19.	周星彤, 沈松杰, 孫強. 中國乳腺癌篩查現狀及進展. 中國醫學前沿雜志(電子版), 2020, 12(3): 6-11.
20.	Kaufman CS, Jacobson L, Bachman BA, et al. Digital documentation of the physical examination: moving the clinical breast exam to the electronic medical record. Am J Surg, 2006, 192(4): 444-449.
21.	Tasoulis MK, Zacharioudakis KE, Dimopoulos NG, et al. Diagnostic accuracy of tactile imaging in selecting patients with palpable breast abnormalities: a prospective comparative study. Breast Cancer Res Treat, 2014, 147(3): 589-598.
22.	蓋小榮, 王振捷, 王健, 等. 觸診成像系統在乳腺疾病健康篩查中的應用研究. 中華健康管理學雜志, 2013, 7(6): 398-401.
23.	顧玉芳, 李國遠. 乳腺觸診成像系統在乳腺疾病早期篩查中的應用分析. 中國初級衛生保健, 2022, 36(4): 77-79.
24.	Tabár L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet, 1985, 1(8433): 829-832.
25.	Nystr?m L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet, 2002, 359(9310): 909-919.
26.	梅霞, 卞方云, 謝雯. 數字乳腺斷層融合X線成像技術在乳腺癌診斷中的應用價值. 影像研究與醫學應用, 2022, 6(6): 175-177.
27.	Bahl M, Gaffney S, McCarthy AM, et al. Breast cancer characteristics associated with 2d digital mammography versus digital breast tomosynthesis for screening-detected and interval cancers. Radiology, 2018, 287(1): 49-57.
28.	Alabousi M, Wadera A, Kashif Al-Ghita M, et al. Performance of digital breast tomosynthesis, synthetic mammography, and digital mammography in breast cancer screening: A systematic review and meta-analysis. J Natl Cancer Inst, 2021, 113(6): 680-690.
29.	Conant EF, Beaber EF, Sprague BL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat, 2016, 156(1): 109-116.
30.	Hofvind S, Hovda T, Holen ?S, et al. Digital Breast tomosynthesis and synthetic 2d mammography versus digital mammography: evaluation in a population-based screening program. Radiology, 2018, 287(3): 787-794.
31.	李軍, 徐阿巧, 單秧女, 等. 數字乳腺斷層融合技術的輻射劑量分析. 浙江創傷外科, 2021, 26(1): 3-5.
32.	李琪, 王慧, 閆赟. 數字乳腺斷層融合成像技術對乳腺癌診斷價值的分析. 影像研究與醫學應用, 2020, 4(10): 107-109.
33.	位寒, 劉鴻利, 王思奇, 等. 數字乳腺三維斷層攝影及全數字化乳腺攝影對乳腺疾病診斷價值對比的初步研究. 臨床放射學雜志, 2019, 38(1): 171-176.
34.	BI-RADS 5th edition. https://www.acr.org/Clinical-Resources/ Reporting-and-Data- Systems/Bi-Rads. Date accessed: January 5, 2023.
35.	閆曄. 中國女性乳腺腺體密度分布及其影響因素的研究. 天津醫科大學, 2014.
36.	唐艷艷. 基于成本-效果評價的我國農村婦女乳腺癌篩查策略優化研究. 華中科技大學, 2019.
37.	吳佳毅, 陳偉國, 梅章懿, 等. 乳腺觸覺成像診斷乳腺疾病臨床價值研究. 中國實用外科雜志, 2012, 32(5): 390-394.
38.	Hooley RJ, Greenberg KL, Stackhouse RM, et al. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology, 2012, 265(1): 59-69.
39.	Teh W, Wilson AR. The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer, 1998, 34(4): 449-450.
40.	Shen S, Zhou Y, Xu Y, et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer, 2015, 112(6): 998-1004.
41.	徐穎. 基于乳腺癌高危因素及風險分級的北京地區女性乳腺癌篩查方案優化研究. 北京協和醫學院, 2021.
42.	譚旸, 張煜, 張誠. 可視化觸診和超聲對觸診陰性乳腺病灶的診斷價值. 中國醫學裝備, 2014, 11(S2): 90-91.
43.	逯超, 黃俊魁, 尹傳昌, 等. 乳腺可視化電子觸覺成像診斷系統在女性乳腺腫塊早期診斷中的應用價值. 中國婦幼保健, 2013, 28(24): 4045-4047.
44.	Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent, 2022, 2(1): 1-9.
45.	Lei S, Zheng R, Zhang S, et al. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med, 2021, 18(3): 900-909.
46.	Wellman PS, Dalton EP, Krag D, et al. Tactile imaging of breast masses: first clinical report. Arch Surg, 2001, 136(2): 204-208.
47.	瞿亞軍, 呂青. 我國乳腺癌預防若干問題的思考. 中國普外基礎與臨床雜志, 2020, 27(11): 1334-1339.
48.	趙亞男. Sure Touch在乳腺疾病診斷上臨床應用價值的研究. 吉林大學, 2011.

1. Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin, 2021, 71(3): 209-249.
2. 孫可欣, 鄭榮壽, 顧秀瑛, 等. 2000—2014年中國腫瘤登記地區女性乳腺癌發病趨勢及年齡變化情況分析. 中華預防醫學雜志, 2018, 52(6): 567-572.
3. 沈松杰, 孫強. 制定中國女性乳腺癌篩查指南的意義. 中國研究型醫院, 2022, 9(2): 23-27.
4. von Euler-Chelpin M, Lillholm M, Vejborg I, et al. Sensitivity of screening mammography by density and texture: a cohort study from a population-based screening program in Denmark. Breast Cancer Res, 2019, 21(1): 111. doi: 10.1186/s13058-019-1203-3.
5. 赫捷, 陳萬青, 李霓, 等. 中國女性乳腺癌篩查與早診早治指南(2021, 北京). 中華腫瘤雜志, 2021, 43(4): 357-382.
6. 張敏璐, 彭鵬, 吳春曉, 等. 2008–2012年中國腫瘤登記地區女性乳腺癌發病和死亡分析. 中華腫瘤雜志, 2019, 41(4): 315-320.
7. 劉慧杰, 劉迪. 超聲乳腺影像報告和數據系統分級在篩查社區女性乳腺癌中的應用. 當代醫學, 2022, 28(11): 152-154.
8. 孫鑫, 韓優莉, 王樂, 等. 超聲檢查用于亞洲女性乳腺癌篩查衛生經濟學研究的系統評價. 中國腫瘤, 2018, 27(7): 553-560.
9. 中國抗癌協會乳腺癌專業委員會. 中國乳腺癌篩查與早期診斷指南. 中國癌癥雜志, 2022, 32(4): 363-372.
10. Kiely BE, Goodwin A. Is it time to abandon clinical breast examination? Med J Aust, 2021, 215(10): 458-459.
11. Egorov V, Sarvazyan AP. Mechanical imaging of the breast. IEEE Trans Med Imaging, 2008, 27(9): 1275-1287.
12. Ding Y, Sun C, Zhou Q, et al. Use of palpation imaging in diagnosis of breast diseases: A way to improve the detection rate. Med Sci Monit, 2020, 26: e927553. doi: 10.12659/MSM.927553.
13. Romanoff A, Constant TH, Johnson KM, et al. Association of previous clinical breast examination with reduced delays and earlier-stage breast cancer diagnosis among women in peru. JAMA Oncol, 2017, 3(11): 1563-1567.
14. Mittra I, Mishra GA, Dikshit RP, et al. Effect of screening by clinical breast examination on breast cancer incidence and mortality after 20 years: prospective, cluster randomised controlled trial in Mumbai. BMJ, 2021, 372: n256. doi: 10.1136/bmj.n256.
15. Malmartel A, Tron A, Caulliez S. Accuracy of clinical breast examination's abnormalities for breast cancer screening: cross-sectional study. Eur J Obstet Gynecol Reprod Biol, 2019, 237: 1-6.
16. NCCN. Breast cancer screening and diagnosis. (version 2022). https://www.nccn.org/patients/guidelines/content/PDF/breastcancerscreening-patient.pdf.
17. Committee on Practice Bulletins—Gynecology. Practice bulletin number 179: breast cancer risk assessment and screening in average-risk women. Obstet Gynecol, 2017, 130(1): e1-e16. doi: 10.1097/AOG.0000000000002158.
18. 沈松杰, 孫強, 黃欣, 等. 中國女性乳腺癌篩查指南(2022年版). 中國研究型醫院, 2022, 9(2): 6-13.
19. 周星彤, 沈松杰, 孫強. 中國乳腺癌篩查現狀及進展. 中國醫學前沿雜志(電子版), 2020, 12(3): 6-11.
20. Kaufman CS, Jacobson L, Bachman BA, et al. Digital documentation of the physical examination: moving the clinical breast exam to the electronic medical record. Am J Surg, 2006, 192(4): 444-449.
21. Tasoulis MK, Zacharioudakis KE, Dimopoulos NG, et al. Diagnostic accuracy of tactile imaging in selecting patients with palpable breast abnormalities: a prospective comparative study. Breast Cancer Res Treat, 2014, 147(3): 589-598.
22. 蓋小榮, 王振捷, 王健, 等. 觸診成像系統在乳腺疾病健康篩查中的應用研究. 中華健康管理學雜志, 2013, 7(6): 398-401.
23. 顧玉芳, 李國遠. 乳腺觸診成像系統在乳腺疾病早期篩查中的應用分析. 中國初級衛生保健, 2022, 36(4): 77-79.
24. Tabár L, Fagerberg CJ, Gad A, et al. Reduction in mortality from breast cancer after mass screening with mammography. Randomised trial from the Breast Cancer Screening Working Group of the Swedish National Board of Health and Welfare. Lancet, 1985, 1(8433): 829-832.
25. Nystr?m L, Andersson I, Bjurstam N, et al. Long-term effects of mammography screening: updated overview of the Swedish randomised trials. Lancet, 2002, 359(9310): 909-919.
26. 梅霞, 卞方云, 謝雯. 數字乳腺斷層融合X線成像技術在乳腺癌診斷中的應用價值. 影像研究與醫學應用, 2022, 6(6): 175-177.
27. Bahl M, Gaffney S, McCarthy AM, et al. Breast cancer characteristics associated with 2d digital mammography versus digital breast tomosynthesis for screening-detected and interval cancers. Radiology, 2018, 287(1): 49-57.
28. Alabousi M, Wadera A, Kashif Al-Ghita M, et al. Performance of digital breast tomosynthesis, synthetic mammography, and digital mammography in breast cancer screening: A systematic review and meta-analysis. J Natl Cancer Inst, 2021, 113(6): 680-690.
29. Conant EF, Beaber EF, Sprague BL, et al. Breast cancer screening using tomosynthesis in combination with digital mammography compared to digital mammography alone: a cohort study within the PROSPR consortium. Breast Cancer Res Treat, 2016, 156(1): 109-116.
30. Hofvind S, Hovda T, Holen ?S, et al. Digital Breast tomosynthesis and synthetic 2d mammography versus digital mammography: evaluation in a population-based screening program. Radiology, 2018, 287(3): 787-794.
31. 李軍, 徐阿巧, 單秧女, 等. 數字乳腺斷層融合技術的輻射劑量分析. 浙江創傷外科, 2021, 26(1): 3-5.
32. 李琪, 王慧, 閆赟. 數字乳腺斷層融合成像技術對乳腺癌診斷價值的分析. 影像研究與醫學應用, 2020, 4(10): 107-109.
33. 位寒, 劉鴻利, 王思奇, 等. 數字乳腺三維斷層攝影及全數字化乳腺攝影對乳腺疾病診斷價值對比的初步研究. 臨床放射學雜志, 2019, 38(1): 171-176.
34. BI-RADS 5th edition. https://www.acr.org/Clinical-Resources/ Reporting-and-Data- Systems/Bi-Rads. Date accessed: January 5, 2023.
35. 閆曄. 中國女性乳腺腺體密度分布及其影響因素的研究. 天津醫科大學, 2014.
36. 唐艷艷. 基于成本-效果評價的我國農村婦女乳腺癌篩查策略優化研究. 華中科技大學, 2019.
37. 吳佳毅, 陳偉國, 梅章懿, 等. 乳腺觸覺成像診斷乳腺疾病臨床價值研究. 中國實用外科雜志, 2012, 32(5): 390-394.
38. Hooley RJ, Greenberg KL, Stackhouse RM, et al. Screening US in patients with mammographically dense breasts: initial experience with Connecticut Public Act 09-41. Radiology, 2012, 265(1): 59-69.
39. Teh W, Wilson AR. The role of ultrasound in breast cancer screening. A consensus statement by the European Group for Breast Cancer Screening. Eur J Cancer, 1998, 34(4): 449-450.
40. Shen S, Zhou Y, Xu Y, et al. A multi-centre randomised trial comparing ultrasound vs mammography for screening breast cancer in high-risk Chinese women. Br J Cancer, 2015, 112(6): 998-1004.
41. 徐穎. 基于乳腺癌高危因素及風險分級的北京地區女性乳腺癌篩查方案優化研究. 北京協和醫學院, 2021.
42. 譚旸, 張煜, 張誠. 可視化觸診和超聲對觸診陰性乳腺病灶的診斷價值. 中國醫學裝備, 2014, 11(S2): 90-91.
43. 逯超, 黃俊魁, 尹傳昌, 等. 乳腺可視化電子觸覺成像診斷系統在女性乳腺腫塊早期診斷中的應用價值. 中國婦幼保健, 2013, 28(24): 4045-4047.
44. Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent, 2022, 2(1): 1-9.
45. Lei S, Zheng R, Zhang S, et al. Breast cancer incidence and mortality in women in China: temporal trends and projections to 2030. Cancer Biol Med, 2021, 18(3): 900-909.
46. Wellman PS, Dalton EP, Krag D, et al. Tactile imaging of breast masses: first clinical report. Arch Surg, 2001, 136(2): 204-208.
47. 瞿亞軍, 呂青. 我國乳腺癌預防若干問題的思考. 中國普外基礎與臨床雜志, 2020, 27(11): 1334-1339.
48. 趙亞男. Sure Touch在乳腺疾病診斷上臨床應用價值的研究. 吉林大學, 2011.

CHINESE JOURNAL OF BASES AND CLINICS IN GENERAL SURGERY

The value of breast palpation imaging in breast cancer screening

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Next Article

Format

Content